Carl Zeiss Meditec AG (CHIX:AFXd)
€ 50.58 -1.625 (-3.11%) Market Cap: 4.41 Bil Enterprise Value: 4.52 Bil PE Ratio: 28.30 PB Ratio: 2.11 GF Score: 87/100
Back to the Transcripts List

Q4 2024 Carl Zeiss Meditec AG Earnings Call Transcript

Dec 11, 2024 / 09:00 AM GMT
Release Date Price: €56.68 (-7.70%)

Key Points

Positve
  • Carl Zeiss Meditec AG (CZMWF) has launched new innovative products like the Kinevo 900 S and VisoMax 800, which are expected to enhance their market position.
  • The company has shown resilience by implementing cost control measures, resulting in a slight decrease in OPEX despite revenue softness.
  • There is a strong market position in China, with a market share of over 50% in refractive procedures.
  • The integration of DORC is progressing well, with synergies already being realized in sales and R&D.
  • Recurring revenue has expanded to 47% of total revenue, indicating a stable income stream.
Negative
  • The fiscal year 2024 was challenging with a decline in both revenue and profit, primarily due to a restrictive investment climate and weaker consumer sentiment.
  • Reported EBIT dropped significantly by 44% year-on-year, with an EBIT margin falling from 16.7% to 9.4%.
  • There are ongoing pressures in the Chinese market, with a decline in consumer confidence and a shift towards more price-sensitive procedures.
  • The company faces headwinds from currency fluctuations, particularly from RMB, USD, and JPY.
  • Despite cost control measures, the OPEX ratios remain elevated due to revenue weakness.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AFXG.DE - Carl Zeiss Meditec AG
Q4 2024 Carl Zeiss Meditec AG Earnings Call
Dec 11, 2024 / 09:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everybody. Thank you for joining us here in Berlin for our annual results conference for the fiscal year 2,324. I'm Sebastian. I'm the head of Investor Relations. Thanks everybody for coming here from different regions of the world for our analyst and shareholder base. We really appreciate spending this conference with you quick organizational comments and then we can go into the presentation Maybe the wifi first because the Wi Fi from the guest rooms for those who have stayed in the hotel is quite bad down here. So please use this one, the meeting room and the passwords conferences. 2023 on today's agenda. We are planning to spend a maximum of 90 minutes or so on the results presentation in Q&A together with our
Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.